Physician profile
Amir H Fathi
NPI 1396908398
$254,761.69
in general payments reported to CMS, 2019-2025
10 companies · $42K in 2025
The $42K reported for 2025 was more than what 99% of Surgical Oncology providers received nationally (typical 2025 total: $288).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $64K · 2020: $36K · 2021: $12K · 2022: $41K · 2023: $23K · 2024: $37K · 2025: $42K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $72K · Travel and Lodging: $23K · Food and Beverage: $2,975 · Education: $2,500 · Honoraria: $1,620 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $71,800.00 |
| Travel and Lodging | $23,193.72 |
| Food and Beverage | $2,974.57 |
| Education | $2,500.00 |
| Honoraria | $1,620.00 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $189,644.91 | 2019-2025 | |
| Davol INC. | $46,437.40 | 2019-2025 | Phasix Mesh |
| Intuitive Surgical, INC. | $16,654.32 | 2019-2024 | Davinci Xi, Da Vinci Surgical System |
| Ipsen Biopharmaceuticals, INC | $1,305.00 | 2022 | |
| Ethicon US, LLC | $328.53 | 2025 | Harmonic, Stratafix, Echelon Endopath |
| Daiichi Sankyo INC. | $151.27 | 2023 | |
| Smith+Nephew, INC. | $115.00 | 2019 | |
| Karl Storz Endoscopy-America | $86.29 | 2025 | Na |
| Integra Lifesciences Corporation | $23.30 | 2021 | |
| Ibsa Pharma INC. | $15.67 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amir Fathi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.